Rossby Financial’s Bio-Techne TECH Stock Holding History

Rossby Financial’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41K	Buy	20 +13	+186%	+$702	﹤0.01%	1825
2026 Q1	$374	Buy	7 +5	+250%	+$300	﹤0.01%	2133
2025 Q4	$118	Buy	+2	New	+$122	﹤0.01%	1784

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rossby Financial's TECH Position: Q2 2026 in Review

Rossby Financial increased its Bio-Techne (TECH) stake by 186% in Q2 2026, buying an estimated $702 and bringing the position to 20 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Rossby Financial first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Rossby Financial held 20 shares of Bio-Techne worth $1.41K as of Q2 2026.
Rossby Financial bought 13 Bio-Techne shares in Q2 2026, an estimated $702.
Bio-Techne made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1825 holding.
Rossby Financial first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.